FTSE All-Share
5.316,96
PKT
-9,75
PKT
-0,18
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.02.18 | National Grid overweight | Morgan Stanley | |
| 13.02.18 | HSBC overweight | Morgan Stanley | |
| 13.02.18 | London Stock Exchange (LSE) overweight | Morgan Stanley | |
| 13.02.18 | BP Equal-Weight | Morgan Stanley | |
| 13.02.18 | Shell (ex Royal Dutch Shell) overweight | Morgan Stanley | |
| 13.02.18 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 13.02.18 | Rio Tinto buy | Deutsche Bank AG | |
| 12.02.18 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 12.02.18 | Lloyds Banking Group buy | UBS AG | |
| 12.02.18 | Vodafone Group overweight | Barclays Capital | |
| 12.02.18 | Barclays buy | UBS AG | |
| 12.02.18 | Vodafone Group Outperform | Credit Suisse Group | |
| 12.02.18 | HSBC Neutral | UBS AG | |
| 12.02.18 | BP buy | Société Générale Group S.A. (SG) | |
| 12.02.18 | AstraZeneca Hold | S&P Capital IQ | |
| 12.02.18 | Imperial Brands Outperform | RBC Capital Markets | |
| 12.02.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.02.18 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 09.02.18 | HSBC Hold | Deutsche Bank AG | |
| 09.02.18 | Barclays buy | Deutsche Bank AG | |
| 09.02.18 | GSK Hold | Deutsche Bank AG | |
| 09.02.18 | AstraZeneca Hold | S&P Capital IQ | |
| 09.02.18 | GSK Hold | Kepler Cheuvreux | |
| 09.02.18 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.02.18 | Rio Tinto Hold | HSBC | |
| 08.02.18 | Imperial Brands Neutral | JP Morgan Chase & Co. | |
| 08.02.18 | Imperial Brands buy | Société Générale Group S.A. (SG) | |
| 08.02.18 | Rio Tinto buy | Deutsche Bank AG | |
| 08.02.18 | GSK Hold | Deutsche Bank AG | |
| 08.02.18 | Imperial Brands kaufen | Deutsche Bank AG | |
| 08.02.18 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.02.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.02.18 | BT Group Outperform | Bernstein Research | |
| 08.02.18 | GSK market-perform | Bernstein Research | |
| 08.02.18 | BT Group buy | UBS AG | |
| 08.02.18 | GSK buy | UBS AG | |
| 08.02.18 | BT Group buy | UBS AG | |
| 08.02.18 | Rio Tinto buy | UBS AG | |
| 08.02.18 | GSK Neutral | Credit Suisse Group | |
| 08.02.18 | GSK Neutral | JP Morgan Chase & Co. |